Healthcare | April 20, 2026
Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts
Medical experts point to a growing body of research linking energy drinks to liver injury
Medical experts point to a growing body of research linking energy drinks to liver injury
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Subscribe To Our Newsletter & Stay Updated
